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A novel one-pot tandem biohydrogen transfer process to 
concurrently obtain two enantiopure sec-alcohols is 
presented; thus, using a suitable single enzyme and a 
catalytic amount of cofactor several interesting building 
blocks could be easily achieved in an 
enantiocomplementary fashion minimizing dramatically the 
quantity of reagents usually employed in the ‘coupled-
substrate’ approach. 
 
Several (bio)catalytic methods to synthesize enantiopure 
secondary alcohols have been developed in the last few years 
to fulfill the increasing demand of this type of highly valuable 
compounds.1 Among all methodologies described, 
stereoselective reduction of ketones2 and enantioselective 
oxidation of racemic sec-alcohols3 using hydrogen transfer 
(HT) protocols have extensively been studied due to the mild 
and simple conditions employed in these transformations. In 
this context, biocatalyzed HT (also called ‘coupled-substrate’ 
approach) employing alcohol dehydrogenases (ADHs) has 
recently gained increasing relevance.4 In these processes, a 
single enzyme reduces/oxidizes the target substrate sacrificing 
a small molecule (cosubstrate) like 2-propanol/acetone as 
hydride donor/acceptor, used in a huge molar excess (at least 
10 equiv. compared to 1 equiv. substrate to afford conversions 
higher than 90%) due to the reversible character of the 
reaction. 
 
 
Scheme 1 Tandem ADH-catalyzed hydrogen transfer concept. 
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Very recently, it has been described that small activated 
ketones such as methyl acetoacetate5 or chloroacetone6 can be 
employed as cosubstrates in ADH-catalyzed oxidation of 
alcohols in near stoichiometric amount to achieve complete 
conversion. Herein, we present a system in which the 
sacrificial reaction has been turned into a highly valuable 
transformation, resulting in a one-pot process combining 
activated ketones with racemic sec-alcohols in order to 
concurrently obtain two different optically enriched alcohols 
catalyzed by a single enzyme maximizing thus the atom 
efficiency environmental factor E7 of the process, since no 
additional reagent is discarded. Therefore, starting from a 
prochiral ketone and a racemic alcohol, we can obtain two 
optically pure alcohols (Scheme 1). Another advantage of this 
system is that the stereoselectivity can be tuned by simply 
changing the biocatalyst employed. 
 
In a first set of experiments, we studied the influence of the 
ketone structure on some selected ADH-catalyzed reductions 
using a low excess of the cosubstrate (2 equiv. of 2-propanol, 
see Supporting Information). Thus, several ketones were 
reduced using a Prelog (ADH-A from Rhodococcus ruber),8 or 
an anti-Prelog [ADH from Lactobacillus brevis (LB-ADH)]9 
enzyme. It could be observed that non-activated ketones like 
acetophenone afforded 50% conversion. When p-substituted 
acetophenones were reduced, electron donating groups 
provided low conversions (<30%), while electron withdrawing 
substituents afforded conversions about 80%. Moreover, 
ketones with an electron withdrawing group at α-position such 
as α-chloroacetophenone furnished quantitative conversions. 
These results can be explained due to the different oxidation-
reduction potentials (ΔEO) between the ketone/alcohol pair 
with regards to the 2-propanol/acetone counterpart.10 It has 
been shown that α-halohydrins are stabilized via 
intramolecular H-bond between the alcohol moiety and the 
halogen atom,11 therefore preventing the ADH-catalyzed 
oxidation.6 
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Table 1. Tandem Concurrent Biohydrogen Transfer Using Activated Ketones and 2-Octanola 
OH
ADH / Tris.HCl buffer
OH
X
R
O
X
R
rac-3a
*
1a-k
+ OH
(R) or (S)-3a
(R) or (S)-2a-k
+
*
30 ºC / 24 h
1a, R = p-H, X = Cl
1b, R = p-OH, X = Cl
1c, R = p-Me, X = Cl
1d, R = p-Cl, X = Cl
1e, R = m,p-Cl, X = Cl
O Cl
O
1j
MeO
OO
Cl
1k
1f, R = m-NO2, X = Cl
1g, R = p-NO2, X = Cl
1h, R = H, X = N3
1i, R = H, X = CN
 
  Prelog ADH anti-Prelog ADH 
entry ketone enzyme 2a-k 3a enzyme 2a-k 3a 
   convb ee (%)c ee (%)c  convb ee (%)c,d ee (%)c 
1 1a ADH-A 81 >99 (R)d 83 (R) LB-ADH 90 >99 (S) 98 (S) 
2 1be ADH-A 57 >99 (R)d 44 (R) LB-ADH 83 >99 (S) 79 (S) 
3 1c ADH-A 97 >99 (R) 94 (R) LB-ADH 94 >99 (S) 92 (S) 
4 1d ADH-A 85 >99 (R)d 88 (R) LB-ADH 86 >99 (S) 88 (S) 
5 1e ADH-Af 93 99 (R)d 98 (R) PR2 90 99 (S) >99 (S) 
6 1fe ADH-A 89 >99 (R)d 99 (R) LB-ADH 90 >99 (S) 98 (S) 
7 1g ADH-A 91 >99 (R)d >99 (R) LB-ADH 90 >99 (S) >99 (S) 
8 1he ADH-T 73 >99 (R)d 70 (R) PR2 84 >99 (S) 90 (S) 
9 1i ADH-Te 78 >99 (S) 72 (R) g -- -- -- 
10 1j ADH-Ae 85 >99 (R)d 94 (R) LB-ADH 87 >99 (S) 94 (S) 
11 1k ADH-Tf >99 >99 (R)d >99 (R) LB-ADHh >99 >99 (S) >99 (S) 
a Enzyme: (3-5 U); [1]: 50 mM; [3a]: 90 to 100 mM; [NAD(P)H]: 1 mM. b Measured by achiral GC. c Measured by chiral GC or HPLC. d Switch in Cahn-
Ingold-Prelog priority (CIP). e [3a]: 45 mM. f [3a]: 180 mM. g Not appropriate ADH found. h [3a]: 400 mM. 
 
Taking as an advantage the irreversibility of this HT, we 
tested the concept in a one-pot tandem protocol to 
simultaneously obtain two enantiopure sec-alcohols (see 
Scheme of Table 1). In theory, an irreversible asymmetric 
reduction is required to achieve a complete kinetic oxidative 
resolution, thus a molar amount of ketone to be reduced can be 
equal or slightly higher than the molar amount of alcohol to be 
oxidized. Thus, mixing an activated ketone (1 equiv.) with a 
racemic alcohol (1.8-2 equiv.), the selective reduction of the 
prochiral compound plus the kinetic resolution of the racemate 
could be achieved via HT by a single enzyme and a catalytic 
amount of the pyrimidinic cofactor which is internally 
recycled. Due to the perfect selectivity shown by the 
biocatalysts utilized, the hydride is abstracted from a single 
enantiomer of the racemic alcohol, and then exclusively 
transferred to one stereo-face of the prochiral ketone. 
Therefore, several α-chloro-, α-azido-, and α-cyano ketones 
(1a-k, Table 1) were purchased or synthesized and then 
combined with racemic 2-octanol (3a). Except for the cyano 
derivative 1i (entry 9), we were able to find a suitable Prelog 
and anti-Prelog ADH to obtain enantioenriched or enantiopure 
(R)- or (S)-3a using activated aliphatic and (hetero)aryl 
ketones, which were reduced to the corresponding enantiopure 
alcohols with very high yields. Compounds with electron 
donating groups in the phenyl ring (1b, entry 2), afforded 
lower conversions. By simply changing the enzyme, 
enantiocomplementary products could be achieved. Thus, 
ADH-A or LB-ADH were usually employed, but in some 
cases Thermoanaerobacter sp. ADH (ADH-T)12 or PR2 
provided better results. As an example, we scaled-up the 
reaction of 2k with LB-ADH up to a substrate concentration 
of 400 mM, showing the great robustness of the system. The 
obtained α-activated alcohols are important precursors of 
pharmaceutical compounds. For instance, (S)-2a is an 
intermediate for the synthesis of fluoxetine, tomoxetine, and 
nisoxetine,13 (R)-2b can be used as precursor of β-agonists like 
octopamine or denopamine,14 and optically active 2k is a 
useful chiral building block for the synthesis of different 
pharmaceuticals.15 
On the other hand, several sec-alcohols were resolved using 
chloro ketone 1e with ADH-A, and 1k with LB-ADH (Table 
2). Thus, aromatic (3b-d), aliphatic (3e-f) such as sulcatol, or 
cycloalkyl (3g) derivatives could be successfully obtained in 
enantioenriched form via tandem concurrent HT. 
 
Table 2. Resolution of sec-Alcohols via ADH-Catalyzed Tandem HT 
Mediated by α-Chloro Ketonesa 
R1
OH
ADH / Tris.HCl buf fer
R
OH
Cl
R
O
Cl
rac-3b-g
*
1e or 1k
+
R1
OH
(R) or (S)-3b-g
(R)-1e or (S)-1k
+
*
30 ºC / 24 h
3b, R1 = Ph; 3c, R1 = m-ClC6H4; 3d, R1 = p-OMeC6H4
3e, R1 = C9H20; 3f, R1 = Me2CH=CH(CH2)2; 3g, R1 = cyclohexyl  
 ADH-A LB-ADH  
alcohol 1e 3b-g 1k 3b-g 
 convb ee (%)c,d ee (%)c convb ee (%)c,d ee (%)c 
3b 90 99 (R) 99 (R) >99 >99 (S) >99 (S) 
3c 85 99 (R) 81 (R) 94 >99 (S) 87 (S) 
3d 91 99 (R) >99 (R) 99 >99 (S) >99 (S) 
3e 93 99 (R) 95 (R) 97 >99 (S) 96 (S) 
3f 95 99 (R) >99 (R) >98 >99 (S) >99 (S) 
3g 94 99 (R) 98 (R) >98 >99 (S) >99 (S) 
a Enzyme: (3-5 U); [1]: 50 mM; [3a]: 90 to 100 mM; [NAD(P)H]: 1 
mM. b Measured by achiral GC. c Measured by chiral GC. d Switch in CIP. 
 
In summary, we have demonstrated a novel one-pot tandem 
system to simultaneously obtain two enantiopure sec-alcohols 
that possesses several advantages: conversion can be easily 
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controlled by the amount of racemic alcohol added, a single 
biocatalyst and catalytic amount of cofactor are used, the 
selectivity can be tuned by choosing the appropriate enzyme, 
and the process can be scaled-up.16 This is an elegant example 
that shows how biocatalysis can be applied for the “clean” 
synthesis of valuable enantiopure compounds maximizing the 
atom efficiency.7 
 
Experimental Section 
 
General. Alcohol dehydrogenases, ketones 1a, 1d, 1e, 1i, 
1k, racemic alcohols 3a, 3b, 3c, 3d, 3e, 3f and 3g, and their 
corresponding ketones were purchased from commercial 
sources. α-Chloro ketones 1b, 1c, 1f, 1g, and 1j were 
synthesized following modified protocols described in the 
literature.17 α-Azido ketone 1h was obtained as published 
before.8a Racemic alcohols 2a-k were synthesised by 
conventional reduction from the corresponding ketones 
(NaBH4, MeOH, room temperature). All other reagents and 
solvents were of the highest quality available. 1 unit (U) of 
ADH reduces 1.0 μM of acetophenone to 1-phenylethanol per 
minute at pH 7.5 and 30ºC in the presence of NAD(P)H. Flash 
chromatography was performed using silica gel 60 (230-400 
mesh). 
 
General procedure for the tandem concurrent 
biohydrogen transfer using activated ketones and 2-
octanol. In a 1.5 mL Eppendorf vial, 3-5 U of commercially 
available ADH (Lactobacillus brevis ADH, Rhodococcus 
ruber ADH-A, Thermoanaerobacter sp. ADH or PR2 ADH) 
in Tris-HCl buffer [50 mM, pH 7.5, 1 mM NAD(P)H, 1 mM 
MgCl2 for LB-ADH] were mixed with both the racemic 2-
octanol and the prochiral ketone (1a-k) in a 1.8-2:1 molar ratio 
respectively (e.g., 90-100 mM racemic 3a and 50 mM ketone) 
in a final volume of 0.6 mL. The reaction was incubated at 30 
ºC and orbital rotation (150 rpm) for 24h. Then, the reaction 
was stopped by extraction with ethyl acetate (2 x 0.6 mL). The 
organic layer was separated by centrifugation (2 min, 13000 
rpm) and dried (Na2SO4). Conversions and enantiomeric 
excesses of the corresponding alcohols were determined by 
GC or HPLC analysis using an achiral or chiral stationary 
phase, respectively. 
 
General procedure for the resolution of sec-alcohols via 
ADH-catalyzed tandem HT mediated by α-chloro ketones. 
In a 1.5 mL Eppendorf vial, 3-5 U of commercially available 
ADH (LB-ADH or ADH-A) in Tris-HCl buffer [50 mM, pH 
7.5, 1 mM NAD(P)H, 1 mM MgCl2 for LB-ADH] were mixed 
with both the racemic alcohol (3b-g, 90-100 mM) and the 
prochiral ketone (1e for ADH-A or 1k for LB-ADH, 50 mM) 
in a final volume of 0.6 mL. The reaction was incubated at 30 
ºC and orbital rotation (150 rpm) for 24h. Then, the reaction 
was stopped by extraction with ethyl acetate (2 x 0.6 mL). The 
organic layer was separated by centrifugation (2 min, 13000 
rpm) and dried (Na2SO4). Conversions and enantiomeric 
excesses of the corresponding alcohols were determined by 
GC or HPLC analysis using an achiral or chiral stationary 
phase, respectively. 
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